Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Witold Ruzyllo

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 12, 2010
The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathyMariusz Klopotowski, Lidia Chojnowska, Lukasz A Malek, et al.
Journal of the American College of Cardiology|July 4, 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trialMichael P Hudson, Paul W Armstrong, Witold Ruzyllo, et al.
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
BMJ (Clinical Research Ed.)|January 18, 2006
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational studyCaroline A Daly, Bianca De Stavola, Jose L Lopez Sendon, et al.
International Journal of Cardiology|April 16, 2013
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT)Christopher B Overgaard, Vladimír Džavík, Christopher E Buller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)Irene M Lang, Sandra A Forman, Aldo P Maggioni, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
The New England Journal of Medicine|November 6, 2007
Prasugrel versus clopidogrel in patients with acute coronary syndromesStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.
European Heart Journal|September 2, 2005
Public awareness of heart failure in Europe: first results from SHAPEWillem J Remme, John J V McMurray, Bernhard Rauch, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trialBimmer E Claessen, Marcel A Beijk, Victor Legrand, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 12, 2010
The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathyMariusz Klopotowski, Lidia Chojnowska, Lukasz A Malek, et al.
Journal of the American College of Cardiology|July 4, 2006
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trialMichael P Hudson, Paul W Armstrong, Witold Ruzyllo, et al.
JAMA Cardiology|July 28, 2016
Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical TrialJohn H Alexander, Ulrika Andersson, Renato D Lopes, et al.
BMJ (Clinical Research Ed.)|January 18, 2006
Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational studyCaroline A Daly, Bianca De Stavola, Jose L Lopez Sendon, et al.
International Journal of Cardiology|April 16, 2013
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT)Christopher B Overgaard, Vladimír Džavík, Christopher E Buller, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 10, 2010
Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT)Irene M Lang, Sandra A Forman, Aldo P Maggioni, et al.
The American Journal of Cardiology|February 22, 2005
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)Manesh R Patel, Kenneth W Mahaffey, Paul W Armstrong, et al.
The New England Journal of Medicine|November 6, 2007
Prasugrel versus clopidogrel in patients with acute coronary syndromesStephen D Wiviott, Eugene Braunwald, Carolyn H McCabe, et al.
European Heart Journal|September 2, 2005
Public awareness of heart failure in Europe: first results from SHAPEWillem J Remme, John J V McMurray, Bernhard Rauch, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trialBimmer E Claessen, Marcel A Beijk, Victor Legrand, et al.
Pageof 11